Navigation Links
Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
Date:11/30/2009

MINNEAPOLIS, Nov. 30 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, was awarded Frost and Sullivan's 2009 North American Product Line Strategy Award in Remote Patient Monitoring. Recognized for providing secure, accurate remote physiological monitoring, Nonin Medical was acknowledged for its leadership as a premier provider of telemedicine monitoring equipment.

The Product Line Strategy award is chosen by Frost and Sullivan's analyst team, which conducts interviews with suppliers, end-users and industry experts to determine the product that best addresses market needs and dynamics. "As the world of telemedicine continues to evolve, there is a need for monitoring companies to develop new monitoring devices in order to perform that critical first step of any telemedicine system, vital sign or data acquisition," observed industry analyst Zachary Bujnoch. "Nonin Medical has already established itself as a true thought leader in this monitoring specific side of remote medicine."

With rising healthcare costs driving care into the home, Nonin's vision of remote monitoring has focused on how to provide cost-effective, accurate physiological data exchange with no proprietary boundaries. Nonin's choice to promote secure information exchange and interoperability has enabled a simpler delivery of health care for telemedicine systems, healthcare systems, systems integrator partners and patients worldwide. Nonin's remote monitoring solutions have provided patients with better information about their health status and allowed clinicians to monitor vital signs with greater ease across the globe.

Together with other industry leaders within the Continua Health Alliance, Nonin is contributing to the advancement of interoperable devices and open standards development to promote the Personal Health ecosystem. "Through these partnerships, our goal for interoperable remote monitoring is to simplify the delivery of health care with an end result that will ultimately benefit both the patient and provider with reduced costs, added security, improved efficiencies and increased compliance rates," said Jayant Parthasarathy, Ph.D., eHealth Business Manager at Nonin Medical and Chairperson of the Continua Health Alliance Technical Working Group.

Known for its accurate PureSAT® pulse oximetry technology, innovative design, low power consumption and unmatched durability, Nonin's vital sign monitoring solutions have become the gold standard for assessment of a wide range of chronic disease conditions, such as COPD, CHF and asthma.

About Nonin Medical, Inc. - www.nonin.com

Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 100+ OEM partners worldwide. With over 20 years of industry-leading capabilities in signal processing and sensor design expertise, Nonin's innovative noninvasive physiological technologies enable clinicians to accurately monitor a patient's true condition in the most challenging environments.

About Frost & Sullivan - www.frost.com

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

SOURCE Nonin Medical, Inc.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
2. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
3. Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
4. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
5. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
6. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification
7. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
8. Nonin Medical Recognized for Influential Contributions in Medical Technology
9. Noninvasive Breath Test Predicts Survival in Patients with Viral Hepatitis
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):